Rezolute, Inc. - 8-K Filing
Rezolute, Inc. releases investor presentation highlighting $108 million cash position and clinical milestones for ersodetug. (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $RZLT
Read the full article at SEC EDGAR
Part of the story Equillium, Inc. - 8-K Filing (3 articles)